Debrisoquine is an antihypertensive agent belonging to the class of anti-adrenergic neuron drugs. It is used to lower elevated blood pressure, thereby preventing vascular damage, reducing mortality, and improving quality of life in hypertensive patients. Its antihypertensive effect is achieved by interfering with the release and depleting the storage of norepinephrine at sympathetic nerve terminals, which reduces sympathetic nervous activity and leads to a decrease in blood pressure. It exhibits a strong and relatively long-lasting hypotensive effect without central sedative action.